Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-17-014542

Options or other derivatives

  • Chief Executive Officer acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
FLESHER GREGORY J. Chief Executive Officer 2017-05-24 Grant or award · Stock Option (Right to Buy) +250,000 250,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…